Education
About Us
Working with TipRanks
Follow Us
SPDR S&P Pharmaceuticals ETF (XPH)
NYSEARCA:XPH
XPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$38.88 - $48.76
Previous CloseN/A
Volume24.55K
Average Volume (3M)36.66K
Market Cap
$162.31M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.89
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Mar 24, 2025Dividend Yield1.65%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume38,756
30 Day Avg. Volume36,663
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$68.03Price Target Upside58.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering338
---
SPDR S&P Pharmaceuticals ETF News
PremiumStock Analysis & Ideas
2 Pharma-Focused ETFs with More Than 20% Upside – December 2023---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
5.05% Other Institutional Investors
89.79% Public Companies and
Individual Investors
XPH FAQ
What was SPDR S&P Pharmaceuticals ETF’s price range in the past 12 months?
SPDR S&P Pharmaceuticals ETF lowest stock price was $38.88 and its highest was $48.76 in the past 12 months.
What is SPDR S&P Pharmaceuticals ETF’s market cap?
SPDR S&P Pharmaceuticals ETF’s market cap is $162.31M.
When is SPDR S&P Pharmaceuticals ETF’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SPDR S&P Pharmaceuticals ETF’s earnings last quarter?
Currently, no data Available
Is SPDR S&P Pharmaceuticals ETF overvalued?
According to Wall Street analysts SPDR S&P Pharmaceuticals ETF’s price is currently Undervalued.
Does SPDR S&P Pharmaceuticals ETF pay dividends?
SPDR S&P Pharmaceuticals ETF pays a Quarterly dividend of $0.153 which represents an annual dividend yield of 1.65%. See more information on SPDR S&P Pharmaceuticals ETF dividends here
What is SPDR S&P Pharmaceuticals ETF’s EPS estimate?
SPDR S&P Pharmaceuticals ETF’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SPDR S&P Pharmaceuticals ETF have?
Currently, no data Available
What happened to SPDR S&P Pharmaceuticals ETF’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SPDR S&P Pharmaceuticals ETF?
Currently, no hedge funds are holding shares in XPH
---
SPDR S&P Pharmaceuticals ETF Stock Smart Score
Technical Analysis
---